Common Contracts
10 similar Indenture contracts by Cv Therapeutics Inc, Nektar Therapeutics, Vertex Pharmaceuticals Inc / Ma, others
INDENTURE between NEKTAR THERAPEUTICS, as Issuer and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION as Trustee 3.25% CONVERTIBLE SUBORDINATED NOTES DUE 2012 Dated as of September 28, 2005Indenture • September 28th, 2005 • Nektar Therapeutics • Pharmaceutical preparations • New York
INDENTURE, dated as of September 28, 2005, between NEKTAR THERAPEUTICS, a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 150 Industrial Road, San Carlos, California 94070 (the “Company”), and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as Trustee (the “Trustee”), having its principal corporate trust office at 600 Travis Street, Suite 1150, Houston, Texas 77002.
CV THERAPEUTICS, INC. as Issuer and WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of July 1, 2005 3¼% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2013Indenture • July 6th, 2005 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of July 1, 2005, between CV THERAPEUTICS, INC., a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 3172 Porter Drive, Palo Alto, California 94304 (the “Issuer” or the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee (the “Trustee”), having its principal corporate trust office at Sixth & Marquette, MAC N9303-120, Minneapolis, MN 55479.
INDENTURE BETWEEN VERTEX PHARMACEUTICALS INCORPORATED, AS ISSUER AND US BANK NATIONAL ASSOCIATION, AS TRUSTEE 5¾% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2011 DATED AS OF SEPTEMBER 17, 2004Indenture • September 17th, 2004 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
INDENTURE, dated as of September 17, 2004, between VERTEX PHARMACEUTICALS INCORPORATED, a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts, having its principal office at 130 Waverly Street, Cambridge, Massachusetts 02139 (the “Company”), and US BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”), having its principal corporate trust office at One Federal Street, Boston, Massachusetts 02110.
2¾% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2012Indenture • August 6th, 2004 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of May 18, 2004, between CV THERAPEUTICS, INC., a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 3172 Porter Drive, Palo Alto, California 94304 (the “Issuer” or the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee (the “Trustee”), having its principal corporate trust office at Sixth & Marquette, MAC N9303-120, Minneapolis, MN 55479.
MERCURY COMPUTER SYSTEMS, INC., ISSUER AND U.S. BANK NATIONAL ASSOCIATION, TRUSTEEIndenture • May 11th, 2004 • Mercury Computer Systems Inc • Electronic components & accessories • New York
INDENTURE, dated as of April 29, 2004, between MERCURY COMPUTER SYSTEMS, INC., a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts, having its principal office at 199 Riverneck Road, Chelmsford, Massachusetts 01824-2820 (herein called the “Company”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States, as Trustee hereunder (herein called the “Trustee”).
INDENTURE BETWEEN VERTEX PHARMACEUTICALS INCORPORATED, AS ISSUER AND U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE 5¾% CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2011 DATED AS OF FEBRUARY 13, 2004Indenture • February 23rd, 2004 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
INDENTURE, dated as of February 13, 2004, between VERTEX PHARMACEUTICALS INCORPORATED, a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts, having its principal office at 130 Waverly Street, Cambridge, Massachusetts 02139 (the “Company”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”), having its principal corporate trust office at One Federal Street, Boston, Massachusetts 02110.
UNITED RENTALS (NORTH AMERICA), INC. as Issuer and UNITED RENTALS, INC. as Guarantor and THE BANK OF NEW YORK as TrusteeIndenture • November 14th, 2003 • United Rentals Inc /De • Services-equipment rental & leasing, nec • New York
INDENTURE, dated as of October 31, 2003, among UNITED RENTALS (NORTH AMERICA), INC., a corporation duly organized and existing under the laws of the State of Delaware (herein called the “Company”), having its principal office at Five Greenwich Office Park, Greenwich, Connecticut 06830, UNITED RENTALS, INC., a corporation duly organized and existing under the laws of the State of Delaware (herein called “Holdings”) and THE BANK OF NEW YORK, a New York banking corporation, having its principal corporate trust office at 101 Barclay Street, New York, New York 10286, as trustee (herein called the “Trustee”).
INDENTURE between NEKTAR THERAPEUTICS, as Issuer and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION as Trustee 3% CONVERTIBLE SUBORDINATED NOTES DUE 2010 Dated as of October 9, 2003Indenture • October 10th, 2003 • Nektar Therapeutics • Pharmaceutical preparations • New York
INDENTURE, dated as of October 9, 2003, between NEKTAR THERAPEUTICS, a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 150 Industrial Road, San Carlos, California 94070 (the “Company”), and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as Trustee (the “Trustee”), having its principal corporate trust office at 560 Mission Street, 13th Floor, San Francisco, California 94105.
CV THERAPEUTICS, INC. as Issuer and WELLS FARGO BANK MINNESOTA, NATIONAL ASSOCIATION as TrusteeIndenture • August 14th, 2003 • Cv Therapeutics Inc • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of June 18, 2003, between CV THERAPEUTICS, INC., a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 3172 Porter Drive, Palo Alto, California 94304 (the “Issuer” or the “Company”), and WELLS FARGO BANK MINNESOTA, NATIONAL ASSOCIATION, as Trustee (the “Trustee”), having its principal corporate trust office at Sixth & Marquette, MAC N9303-120, Minneapolis, MN 55479.
INDENTURE between NEKTAR THERAPEUTICS, as Issuer and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION as Trustee 3% CONVERTIBLE SUBORDINATED NOTES DUE 2010 Dated as of June 30, 2003Indenture • July 2nd, 2003 • Nektar Therapeutics • Pharmaceutical preparations • New York
INDENTURE, dated as of June 30, 2003, between NEKTAR THERAPEUTICS, a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 150 Industrial Road, San Carlos, California 94070 (the “Company”), and J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as Trustee (the “Trustee”), having its principal corporate trust office at 560 Mission Street, 13th Floor, San Francisco, California 94105.
